CD86 and myeloid sarcoma: In addition to extending this finding by showing abnormal activation-induced upregulation of CD80 and CD86 by B cells of MS patients, we demonstrate that inhibition of either BTK or of mitochondrial respiration can abrogate this aberrant costimulatory molecule upregulation by the patient B cells.